Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human umbilical cord mesenchymal stem cells for decompensated hepatitis B cirrhosis
CTR20231484Phase 2Active
- Sponsor
- Quansheng Biotech
- Start
- Jul 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in cirrhosis (LC), sponsored by Quansheng Biotech. Started Jul 2023; status: active.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
cirrhosis (LC)
Beyond the preview
Go deeper on CTR20231484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231484.